ArticleTranslational gastroenterology and hepatology2026

Durvalumab and bevacizumab plus transarterial chemoembolization in unresectable hepatocellular carcinoma: a new paradigm?

Maen Abdelrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.